miR-146a, a microRNA (miRNA) that regulates inflammatory responses, plays an important role in many inflammatory diseases. Although an in vitro study had suggested that miR-146a is involved in abnormal inflammatory response, being a critical factor in the pathogenesis of chronic obstructive pulmonary disease (COPD), in vivo evidence of its pathogenic role in COPD remains limited. Eight-week-old male B6(FVB)-Mir146tm1.1Bal/J (miR-146a knockout [KO]) and C57BL/6J mice were intratracheally administered elastase and evaluated after 28 d or exposed to cigarette smoke (CS) and evaluated after 5 months. miR-146a expression was significantly increased in C57BL/6J mouse lungs due to elastase administration ( P = 0.027) or CS exposure ( P = 0.019) compared with that in the control group. Compared with C57BL/6J mice, elastase-administered miR-146a-KO mice had lower average computed tomography (CT) values ( P = 0.017) and increased lung volume-to-weight ratio ( P = 0.016), mean linear intercept ( P < 0.001), and destructive index ( P < 0.001). Moreover, total cell ( P = 0.006), macrophage ( P = 0.001), neutrophil ( P = 0.026), chemokine (C-X-C motif) ligand 2/macrophage inflammatory protein-2 ( P = 0.045; in bronchoalveolar lavage fluid [BALF]), cyclooxygenase-2, and matrix metalloproteinase-2 levels were all increased (in the lungs). Following long-term CS exposure, miR-146a-KO mice showed a greater degree of emphysema formation in their lungs and inflammatory response in the BALF and lungs than C57BL/6J mice. Collectively, miR-146a protected against emphysema formation and the associated abnormal inflammatory response in two murine models.